tradingkey.logo
搜索

Salarius Pharmaceuticals Ord Shs

DCOY
添加自选
3.100USD
+0.540+21.09%
收盘 09-22 16:00美东
1.64M总市值
亏损市盈率 TTM
盘前交易 08:05 (美东)4.260USD+1.160+37.42%

关于 公司

Salarius Pharmaceuticals Ord Shs 简介

公司代码- -
公司名称- -
上市日期- -
CEO- -
员工数量- -
证券类型- -
年结日- -
公司地址- -
城市- -
上市交易所- -
国家- -
邮编- -
电话- -
网址- -
公司代码- -
上市日期- -
CEO- -

Salarius Pharmaceuticals Ord Shs公司高管

名称
名称/职务
职务
持股
持股变动
Mr. Mark J. Rosenblum, CPA
Mr. Mark J. Rosenblum, CPA
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
11.36K
+85.21%
Mr. Mark J. Rosenblum, CPA
Mr. Mark J. Rosenblum, CPA
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
11.36K
+85.21%
Mr. Peter Marschel
Mr. Peter Marschel
Chief Business Officer
Chief Business Officer
3.90K
--
Mr. Peter Marschel
Mr. Peter Marschel
Chief Business Officer
Chief Business Officer
3.90K
--
Ms. Tess Burleson
Ms. Tess Burleson
Independent Director
Independent Director
2.00K
+99.90%
Mr. Jonathan I. (Jon) Lieber
Mr. Jonathan I. (Jon) Lieber
Independent Director
Independent Director
2.00K
+99.90%
Ms. Tess Burleson
Ms. Tess Burleson
Independent Director
Independent Director
2.00K
+99.90%
Mr. Jonathan I. (Jon) Lieber
Mr. Jonathan I. (Jon) Lieber
Independent Director
Independent Director
2.00K
+99.90%
Mr. David J. Arthur
Mr. David J. Arthur
Director
Director
34.00
--
Mr. David J. Arthur
Mr. David J. Arthur
Director
Director
34.00
--
查看更多
名称
名称/职务
职务
持股
持股变动
Mr. Mark J. Rosenblum, CPA
Mr. Mark J. Rosenblum, CPA
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
11.36K
+85.21%
Mr. Mark J. Rosenblum, CPA
Mr. Mark J. Rosenblum, CPA
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
11.36K
+85.21%
Mr. Peter Marschel
Mr. Peter Marschel
Chief Business Officer
Chief Business Officer
3.90K
--
Mr. Peter Marschel
Mr. Peter Marschel
Chief Business Officer
Chief Business Officer
3.90K
--
Ms. Tess Burleson
Ms. Tess Burleson
Independent Director
Independent Director
2.00K
+99.90%
Mr. Jonathan I. (Jon) Lieber
Mr. Jonathan I. (Jon) Lieber
Independent Director
Independent Director
2.00K
+99.90%

常见问题

Salarius Pharmaceuticals Ord Shs的前五大股东是谁?

Salarius Pharmaceuticals Ord Shs 的前五大股东如下:Mr. Mark J. Rosenblum, CPA

有多少机构持有Salarius Pharmaceuticals Ord Shs(DCOY)的股份?

截至2026Q1,共有24家机构持有Salarius Pharmaceuticals Ord Shs的股份,合计持有的股份价值约为63.48K,占公司总股份的11.93%。与2025Q4相比,机构持股有所增加,增幅为34985.00。
tradingkey.logo
风险提示:我们的网站和移动应用程序仅提供关于某些投资产品的一般信息。Finsights 不提供财务建议或对任何投资产品的推荐,且提供此类信息不应被解释为 Finsights 提供财务建议或推荐。
投资产品存在重大投资风险,包括可能损失投资的本金,且可能并不适合所有人。投资产品的过去表现并不代表其未来表现。
Finsights 可能允许第三方广告商或关联公司在我们的网站或移动应用程序的任何部分放置或投放广告,并可能根据您与广告的互动情况获得报酬。
© 版权所有: FINSIGHTS MEDIA PTE. LTD. 版权所有